Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

Recent studies indicate that cancer antigen 125 (CA125) response criteria tend to overestimate a tumour reduction measured by standard WHO response criteria in recurrent epithelial ovarian carcinoma. The aim of the study was to validate the recently introduced GCIG (The Gynaecological Cancer Intergr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gronlund, B, Hansen, H H, Høgdall, C, Høgdall, E V S, Engelholm, S A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409573/
https://www.ncbi.nlm.nih.gov/pubmed/14735180
http://dx.doi.org/10.1038/sj.bjc.6601501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409573/
https://www.ncbi.nlm.nih.gov/pubmed/14735180
http://dx.doi.org/10.1038/sj.bjc.6601501

Ejemplares similares